Patent Assignment
Reel/Frame 033813/0230
Change of Name
Recorded: 2014-09-24
Pages: 19
Assignor
NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Executed: 2011-01-10
Assignee
NABRIVA THERAPEUTICS AG
LEBERSTRASSE 20, 1110 VIENNA, AUSTRIA
Covered Properties
(2)
Pleuromutilin Derivatives Containing a Hydroxyamino- or Acyloxyaminocycloalkyl Group
Organic Compounds
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 15, 2007
From: THIRRING, KLAUS; ASCHER, GERD; PAUKNER, SUSANNE; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020130/0910 →
Assignment of Assignor's Interest
Nov 15, 2007
From: MANG, ROSEMARIE; ASCHER, GERD; FERENCIC, MATHIAS; HEILMAYER, WENER
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020130/0912 →
Security Interest
Sep 26, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033833/0311 →
Release of Security Interest
Nov 13, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037040/0320 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Assignment of Assignor's Interest
Dec 17, 2024
From: NABRIVA THERAPEUTICS GMBH
To: ARIVA MED GMBH
Reel/Frame 069613/0184 →
Change of Name
Dec 17, 2024
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 069727/0366 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →